By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Research and development, manufacturing and sales of pharmaceuticals, etc, and related operations1.31B100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
Japan1.18B90.00%
Others130.76M10.00%
